Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 567  
Year : 2020  |  Volume : 19  |  Issue : 3  |  Page : 273-276

Cutaneous malignant melanoma with rarest combination of prostatic and splenic metastases on fluorodeoxyglucose (FDG) positron emission tomography–computed tomography scan

Department of Nuclear Medicine and PET-CT, HCG Cancer Hospital, Department of Radiology, HCG Cancer Centre, Ahmedabad, Gujarat, India

Correspondence Address:
Dr. Digish Shah
Department of Nuclear Medicine and PET-CT, HCG Cancer Hospital, Sola Science City Road, Ahmedabad - 380 060, Gujarat
Login to access the Email id

DOI: 10.4103/wjnm.WJNM_49_19

Rights and Permissions

Cutaneous malignant melanoma (MM) metastases to prostate and spleen are very rarely experienced in clinical setting. As per our knowledge, coexistence of prostate and splenic metastatic MM is not reported worldwide. We are presenting a case of 70-year-old male patients with biopsy and clinically proven case of multifocal cutaneous malignant melanomatous lesions having multiple metastatic lymph nodes and systemic metastases, including prostate and spleen. This is the first case reported worldwide having a combination of prostate and splenic metastases.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded174    
    Comments [Add]    

Recommend this journal